Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
WEST PHARMACEUTICAL SERVICES INC
Last earnings +12.9% on 2026-04-23
Revenue grew 6.3% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
WEST PHARMACEUTICAL SERVICES INC shows $3.07B in FY2025 revenue (+6.3% YoY), a 16.1% net margin, and 15.5% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000105770, latest 10-Q filed 2026-04-23) · EODHD · rules-based read · as of 6/17/2026, 6:06:22 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.83B | $2.89B | $2.95B | $2.89B | $3.07B |
| Gross profit | $1.18B | $1.14B | $1.13B | $999M | $1.10B |
| Operating income | $752M | $734M | $676M | $570M | $585M |
| Net income | $662M | $586M | $593M | $493M | $494M |
| Diluted EPS | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| Net margin | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
| 2026-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Exercise | 296.00 | |
| 2026-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Tax | 84.33 @ $312.07 | $26.3K |
| 2026-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Exercise | 473.59 | |
| 2026-05-12 | Campbell Shane Alden SVP, Proprietary Segment | Tax | 134.93 @ $312.07 | $42.1K |
| 2026-05-04 | Pucci Paolo Director | Award | 791.00 | |
| 2026-05-04 | Michels Douglas A Director | Award | 791.00 | |
| 2026-05-04 | Lockhart Stephen H Director | Award | 791.00 | |
| 2026-05-04 | LAI GOLDMAN MYLA Director | Award | 791.00 | |
| 2026-05-04 | Keller Deborah L Director | Award | 791.00 | |
| 2026-05-04 | Joseph Molly Director | Award | 791.00 | |
| 2026-05-04 | HAUGEN JANET BRUTSCHEA Director | Award | 791.00 |